Authid Inc. (Ipsidy Inc.) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on June 21, 2019, reporting events occurring on June 19 and 20, 2019. Although the request metadata lists the company as "Authid Inc.", the filing text explicitly identifies the registrant as Ipsidy Inc., a Delaware corporation. The report details a private placement of equity securities.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial statements (revenue, profit, cash flow, or margins). The primary financial data relates to a capital raise:
- Capital Raised: Approximately $3.1 million.
- Shares Issued: 38,695,000 shares of common stock.
- Implied Price per Share: Approximately $0.080.
- Transaction Costs: A cash fee of approximately $176,000 paid to registered broker-dealers.
- Warrants Issued: Warrants to acquire approximately 1,277,000 shares at an exercise price of $0.088, exercisable for five years.
Material Changes
The material change reported is the entry into Subscription Agreements with several accredited investors. This transaction increases the company's outstanding share count by 38,695,000 shares and provides immediate liquidity of approximately $3.1 million. The filing does not provide comparative data to a prior period as this is a current event report rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard securities law disclosures. The transaction was conducted under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D, relying on exemptions for sales to accredited investors without general solicitation. The shares issued are subject to transfer restrictions.
Investor Verification Checklist
- Verify the correct legal entity name (Ipsidy Inc. vs. Authid Inc.) and ticker symbol status (listed as "Not Applicable" in the filing).
- Confirm the dilution impact of the 38,695,000 new shares and 1,277,000 warrant shares on existing shareholders.
- Review the full text of the Subscription Agreement (Exhibit 4.1) for specific covenants or conditions not summarized in the 8-K.
- Assess the company's use of the $3.1 million proceeds, which is not detailed in this specific filing.